NOVO DSA FORMATION - A POSSIBLE TRIGGER FOR ITBL IN LIVER ALLOGRAFTS

被引：0
|
作者：
Guel, S. [1 ]
Dziodzio, T. [1 ]
Lederer, A. [1 ]
Schoenemann, C. [2 ]
Lachmann, N. [2 ]
Pratschke, J. [1 ]
Oellinger, R. [1 ]
Seehofer, D. [1 ]
Sucher, R. [1 ]
机构：
[1] Charite Univ Med Berlin, Klin Allgemein Visceral & Transplantat Chirurg, Berlin, Germany
[2] Funkt Bereich Gewebetypisierung & Stammzellen Gew, Berlin, Germany
来源：
TRANSPLANT INTERNATIONAL | 2015年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
028
引用
收藏
页码：8 / 8
页数：1
相关论文
共 50 条
  • [41] Prevention of de novo hepatitis B infection after liver transplantation with allografts from hepatitis B core antibody positive donors
    Dodson, SF
    CLINICAL TRANSPLANTATION, 2000, 14 : 20 - 24
  • [42] Significance of the Early Hepatic Stellate Cell (HSC) Activation on the Fibrotic Evolution of Liver Allografts: The Possible Benefit of Estrogen on this Process
    Ozdemir, B. H.
    Ozgun, G.
    Akdur, A.
    Ozcay, F.
    Haberal, M.
    TRANSPLANTATION, 2017, 101 (05) : 77 - 78
  • [43] A different amyloid formation mechanism: De novo oculoleptomeningeal amyloid deposits after liver transplantation
    Ando, Y
    Terazaki, H
    Nakamura, M
    Ando, E
    Haraoka, K
    Yamashita, T
    Ueda, M
    Okabe, H
    Sasaki, Y
    Tanihara, H
    Uchino, M
    Inomata, Y
    TRANSPLANTATION, 2004, 77 (03) : 345 - 349
  • [44] De novo liver tissue formation in rats using a novel collagen-polypropylene scaffold
    Takimoto, Y
    Dixit, V
    Arthur, M
    Gitnick, G
    CELL TRANSPLANTATION, 2003, 12 (04) : 413 - 421
  • [45] SYNERGISM BETWEEN PLATELET AGGREGATING AGENTS - POSSIBLE TRIGGER MECHANISMS DURING HEMOSTATIC PLUG AND-OR THROMBUS FORMATION
    WONG, SC
    ROCK, GA
    THROMBOSIS AND HAEMOSTASIS, 1981, 46 (01) : 427 - 427
  • [46] MAY DE NOVO DONOR SPECIFIC ANTI HLA ANTIBODIES (DSA) AFFECT THE OUTCOME OF LIVER TRANSPLANT PATIENTS ON CALCINEURINE-INHIBITOR-FREE REGIMEN?
    Meszaros, M.
    Bedoya, J. Ursic
    Thevenin, C.
    Faure, S.
    Riviere, B.
    Costes-Martineau, V.
    Eliaou, J. F.
    Pageaux, G. P.
    TRANSPLANT INTERNATIONAL, 2018, 31 : 17 - 17
  • [47] High prevalence and possible de novo formation of BRAF mutation in metastasized papillary thyroid cancer in lymph nodes
    Vasko, V
    Hu, SY
    Wu, GJ
    Xing, JC
    Larin, A
    Savchenko, V
    Trink, B
    Xing, MZ
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (09): : 5265 - 5269
  • [48] Interstitial Lung Disease in De Novo Heart, Kidney, and Liver Allografts Recipients Treated with Everolimus: Results from Three Large Randomized, Multicenter Studies
    Lopez, P.
    Cibrik, D.
    Fischer, L.
    Kohler, S.
    Tufa, M.
    Lehmkuhl, H.
    TRANSPLANTATION, 2012, 94 (10) : 129 - 129
  • [49] THE FREQUENCY OF DE NOVO DONOR HLA SPECIFIC ANTIBODIES (DSA) AND THEIR ASSOCIATION WITH HISTOLOGICAL FINDINGS AND C4D IMMUNOREACTIVITY IN TRANSPLANT LIVER BIOPSIES.
    Askar, Medhat
    Yerian, Lisa
    Klingman, Lynne
    Zhang, Aiwen
    Liu, Xiuli
    HUMAN IMMUNOLOGY, 2013, 74 : 86 - 86
  • [50] AN HLA CLASS II MATCHING STRATEGY USING SEROLOGY-DEFINED GROUPS PREDICTS DE NOVO DSA FORMATION BETTER THAN CONVENTIONAL HLA MISMATCHES
    Hidalgo, L. G.
    Juarez, I. A. Martinez
    Campbell, P.
    HUMAN IMMUNOLOGY, 2022, 83 : 108 - 109
12345